Dextromethorphan in Fibromyalgia

Summary

Dextromethorphan in Fibromyalgia is a clinical trial^[1].

Key Facts

• Dextromethorphan in Fibromyalgia is in the country of United States^[2].
• Dextromethorphan in Fibromyalgia's instance of is recorded as clinical trial^[3].
• Dextromethorphan in Fibromyalgia's start time is recorded as +2018-06-26T00:00:00Z^[4].
• Dextromethorphan in Fibromyalgia's end time is recorded as +2019-06-01T00:00:00Z^[5].
• Dextromethorphan in Fibromyalgia's sponsor is recorded as University of Alabama at Birmingham^[6].
• Dextromethorphan in Fibromyalgia's main subject is recorded as fibromyalgia^[7].
• Dextromethorphan in Fibromyalgia's number of participants is recorded as {'unit': '1', 'amount': '+15'}^[8].
• Dextromethorphan in Fibromyalgia's title is recorded as Dextromethorphan in Fibromyalgia^[9].
• Dextromethorphan in Fibromyalgia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+23'}^[10].
• Dextromethorphan in Fibromyalgia's ClinicalTrials.gov ID is recorded as NCT03538054^[11].
• Dextromethorphan in Fibromyalgia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Dextromethorphan in Fibromyalgia's research intervention is recorded as dextromethorphan^[13].
• Dextromethorphan in Fibromyalgia's clinical trial phase is recorded as phase II clinical trial^[14].
• Dextromethorphan in Fibromyalgia's research subject recruitment status is recorded as recruiting^[15].
• Dextromethorphan in Fibromyalgia's study type is recorded as interventional study^[16].